These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30288353)

  • 1. MUC16 mutations improve patients' prognosis by enhancing the infiltration and antitumor immunity of cytotoxic T lymphocytes in the endometrial cancer microenvironment.
    Hu J; Sun J
    Oncoimmunology; 2018; 7(10):e1487914. PubMed ID: 30288353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High mutation load, immune-activated microenvironment, favorable outcome, and better immunotherapeutic efficacy in melanoma patients harboring
    Wang Q; Yang Y; Yang M; Li X; Chen K
    Aging (Albany NY); 2020 Jun; 12(11):10827-10843. PubMed ID: 32491995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATM mutations as an independent prognostic factor and potential biomarker for immune checkpoint therapy in endometrial cancer.
    Sun L; Wang RC; Zhang Q; Guo LL
    Pathol Res Pract; 2020 Aug; 216(8):153032. PubMed ID: 32703496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of MUC16 Is Associated With Tumor Mutational Burden and Lymph Node Metastasis in Patients With Gastric Cancer.
    Zhang F; Li X; Chen H; Guo J; Xiong Z; Yin S; Jin L; Chen X; Luo D; Tang H; Mao C; Lian L
    Front Med (Lausanne); 2022; 9():836892. PubMed ID: 35211490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer.
    Li X; Pasche B; Zhang W; Chen K
    JAMA Oncol; 2018 Dec; 4(12):1691-1698. PubMed ID: 30098163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of
    Wang Z; Hou H; Zhang H; Duan X; Li L; Meng L
    Am J Transl Res; 2022; 14(2):849-862. PubMed ID: 35273689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why
    Huang YJ; Cao ZF; Wang J; Yang J; Wei YJ; Tang YC; Cheng YX; Zhou J; Zhang ZX
    World J Clin Cases; 2021 Jun; 9(17):4143-4158. PubMed ID: 34141777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MUC16 stimulates neutrophils to an inflammatory and immunosuppressive phenotype in ovarian cancer.
    Wu Y; Liu Q; Xie Y; Zhu J; Zhang S; Ge Y; Guo J; Luo N; Huang W; Xu R; Liu S; Cheng Z
    J Ovarian Res; 2023 Aug; 16(1):181. PubMed ID: 37644468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. POLE mutations improve the prognosis of endometrial cancer via regulating cellular metabolism through AMF/AMFR signal transduction.
    Li Y; Bian Y; Wang K; Wan XP
    BMC Med Genet; 2019 Dec; 20(1):202. PubMed ID: 31864301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MUC16 C terminal-induced secretion of tumor-derived IL-6 contributes to tumor-associated Treg enrichment in pancreatic cancer.
    Fan K; Yang C; Fan Z; Huang Q; Zhang Y; Cheng H; Jin K; Lu Y; Wang Z; Luo G; Yu X; Liu C
    Cancer Lett; 2018 Apr; 418():167-175. PubMed ID: 29337110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of MUC16 Mutation With Response to Immune Checkpoint Inhibitors in Solid Tumors.
    Zhang L; Han X; Shi Y
    JAMA Netw Open; 2020 Aug; 3(8):e2013201. PubMed ID: 32845327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of MUC16 predicts favourable prognosis in MUC16-mutant cervical cancer related to immune response.
    Wang H; Yan C; Ye H
    Exp Ther Med; 2020 Aug; 20(2):1725-1733. PubMed ID: 32765681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive characterization of MUC16 mutations in lung adenocarcinoma for immunotherapies and prognosis: An observational study.
    Liu T; Wu L; Liu J; Chen H; Zhu B; Qiao D; Zhu Y; Liu T; Chen Q; Hu A
    Medicine (Baltimore); 2023 Nov; 102(44):e35481. PubMed ID: 37932988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immune Microenvironment Comparation Study between EGFR Mutant and EGFR Wild Type Lung Adenocarcinoma Patients Based on TCGA Database].
    Zhu G; Li Y; Shi R; Xu S; Zhang Z; Cao P; Chen C; Liu H; Chen J
    Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):236-244. PubMed ID: 33910272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic adenovirus with MUC16-BiTE shows enhanced antitumor immune response by reversing the tumor microenvironment in PDX model of ovarian cancer.
    Wang Q; Ma X; Wu H; Zhao C; Chen J; Li R; Yan S; Li Y; Zhang Q; Song K; Yuan C; Kong B
    Oncoimmunology; 2022; 11(1):2096362. PubMed ID: 35800156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of a novel microscopic technique for quantifying CA125 binding to circulating mononuclear cells in longitudinal specimens during treatment for ovarian cancer.
    Lakatos K; González G; Hoballah J; Brooker J; Jeong S; Evans C; Krauledat P; Hansen WP; Elias KM; Patankar M; Fülöp V; Konstantinopoulos PA; Cramer DW
    J Ovarian Res; 2022 Feb; 15(1):28. PubMed ID: 35219339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MUC16 mutation predicts a favorable clinical outcome and correlates decreased Warburg effect in gastric cancer.
    Zhao H; Zhang L
    Biochem Biophys Res Commun; 2018 Dec; 506(4):780-786. PubMed ID: 30389134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Association of
    Wang X; Yu X; Krauthammer M; Hugo W; Duan C; Kanetsky PA; Teer JK; Thompson ZJ; Kalos D; Tsai KY; Smalley KSM; Sondak VK; Chen YA; Conejo-Garcia JR
    Cancer Epidemiol Biomarkers Prev; 2020 Sep; 29(9):1792-1799. PubMed ID: 32611582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analyzing and validating the prognostic value and mechanism of colon cancer immune microenvironment.
    Wang X; Duanmu J; Fu X; Li T; Jiang Q
    J Transl Med; 2020 Aug; 18(1):324. PubMed ID: 32859214
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Kanwal M; Ding XJ; Song X; Zhou GB; Cao Y
    Oncotarget; 2018 Feb; 9(15):12226-12239. PubMed ID: 29552305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.